Skip to main content

Table 1 Patient demographics and summary of fusion-guided biopsy findings

From: Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen

  All patients Men with PCa Prostatectomy cohort
Men, no. 101 41 (40.6) 26 (25.7)
Age, year 68.9 ± 8.1 67.8 ± 8.0 65.2 ± 7.2
PSA, ng/ml 10.8 ± 6.1 11.3 ± 6.3 11.2 ± 6.3
Prostate volume, ml 42.1 ± 15.3 39.4 ± 13.6 35.1 ± 11.8
Prior negative biopsy, no. 1.5 ± 0.7 1.4 ± 0.6 1.4 ± 0.6
MRI lesions per patient, no. 1.9 ± 1.0 2.1 ± 1.1 2.4 ± 1.0
PI-RAD score, no. (%)
 2 13 (12.9) 1 (1.0) 0 (0)
 3 31 (30.7) 3 (3.0) 0 (0)
 4 36 (35.6) 19 (18.8) 12 (11.9)
 5 21 (20.8) 18 (17.8) 14 (13.9)
TB cores per patiens 4.2 ± 1.5 4.8 ± 1.6 4.9 ± 1.8
Insignificant PCa - 16 (15.8) 6 (5.9)
Significant PCa - 25 (24.8) 20 (19.8)
Gleason score, no. (%)
 Gleason 6 - 17 (16.8) 6 (5.9)
 Gleason 7 (3 + 4) - 9 (8.9) 8 (7.9)
 Gleason 7 (4 + 3) - 7 (6.9) 5 (5.0)
 Gleason ≥8 - 8 (7.9) 7 (6.9)
  1. Continuous variables reported as mean ± standard deviation
  2. PSA prostate-specific antigen, MRI magnetic resonance imaging, PCa prostate cancer, SB systematic biopsy, TB targeted biopsy